PharmaSGP Holding SE
XETRA:PSG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
PharmaSGP Holding SE
EPS (Diluted)
PharmaSGP Holding SE
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
PharmaSGP Holding SE
XETRA:PSG
|
EPS (Diluted)
€1
|
CAGR 3-Years
15%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
|
ATAI Life Sciences NV
NASDAQ:ATAI
|
EPS (Diluted)
-$2
|
CAGR 3-Years
-44%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
N/A
|
|
|
Bayer AG
XETRA:BAYN
|
EPS (Diluted)
-€3
|
CAGR 3-Years
N/A
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
|
Merck KGaA
XETRA:MRK
|
EPS (Diluted)
€6
|
CAGR 3-Years
-8%
|
CAGR 5-Years
6%
|
CAGR 10-Years
9%
|
|
|
Dermapharm Holding SE
XETRA:DMP
|
EPS (Diluted)
€2
|
CAGR 3-Years
0%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
A
|
Apontis Pharma AG
XETRA:APPH
|
EPS (Diluted)
€0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
PharmaSGP Holding SE
Glance View
PharmaSGP Holding SE engages in the sale and marketing of non-prescription drugs, chemical-free over-the-counter painkillers, as well as herbal medicines. The company is headquartered in Graefelfing, Bayern. The company went IPO on 2020-06-19. The firm produces and develops non-chemical and over-the-counter drugs and other healthcare products.
See Also
What is PharmaSGP Holding SE's EPS (Diluted)?
EPS (Diluted)
1.4
EUR
Based on the financial report for Dec 31, 2023, PharmaSGP Holding SE's EPS (Diluted) amounts to 1.4 EUR.
What is PharmaSGP Holding SE's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
2%
Over the last year, the EPS (Diluted) growth was 37%. The average annual EPS (Diluted) growth rates for PharmaSGP Holding SE have been 15% over the past three years , 2% over the past five years .
